220 related articles for article (PubMed ID: 27594302)
1. Diagnostic utility of epithelial and melanocitic markers with double sequential immunohistochemical staining in differentiating melanoma in situ from invasive melanoma.
Parra-Medina R; Morales SD
Ann Diagn Pathol; 2017 Feb; 26():70-74. PubMed ID: 27594302
[TBL] [Abstract][Full Text] [Related]
2. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
3. Melan-A positive dermal cells in malignant melanoma in situ.
Danga ME; Yaar R; Bhawan J
J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
[TBL] [Abstract][Full Text] [Related]
4. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ.
Kim J; Taube JM; McCalmont TH; Glusac EJ
J Cutan Pathol; 2011 Oct; 38(10):775-9. PubMed ID: 21797920
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Rodić N; Zampella J; Sharma R; Burns KH; Taube JM
J Cutan Pathol; 2015 Nov; 42(11):807-14. PubMed ID: 26239102
[TBL] [Abstract][Full Text] [Related]
6. Detection of Occult Invasion in Melanoma In Situ.
Bax MJ; Johnson TM; Harms PW; Schwartz JL; Zhao L; Fullen DR; Chan MP
JAMA Dermatol; 2016 Nov; 152(11):1201-1208. PubMed ID: 27533878
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry in the diagnosis of melanocytic neoplasms.
Smoller BR
Pathology (Phila); 1994; 2(2):371-83. PubMed ID: 9420908
[TBL] [Abstract][Full Text] [Related]
8. Consecutive Immunohistochemical Staining on a Single Slide is Effective in Confirming Melanocytic Derivation.
Campbell KK; Gardner JM; Hall K; Osborne A; Shalin SC
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):e76-e81. PubMed ID: 30499815
[TBL] [Abstract][Full Text] [Related]
9. The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors.
Alomari AK; Tharp AW; Umphress B; Kowal RP
J Cutan Pathol; 2021 Sep; 48(9):1115-1123. PubMed ID: 33660310
[TBL] [Abstract][Full Text] [Related]
10. [Activation of epidermal melanocytes is independent of epithelial proliferation and vascularization. Immunohistologic study using HMB-45 antibody with review of the literature].
Lommel K; Tronnier M; Wolff HH
Hautarzt; 1996 Aug; 47(8):616-23. PubMed ID: 8964704
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical analysis of pseudomelanocytic nests mimicking melanoma in situ: report of 2 cases.
Nicholson KM; Gerami P
Am J Dermatopathol; 2010 Aug; 32(6):633-7. PubMed ID: 20559116
[TBL] [Abstract][Full Text] [Related]
12. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
13. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin.
Beltraminelli H; Shabrawi-Caelen LE; Kerl H; Cerroni L
Am J Dermatopathol; 2009 May; 31(3):305-8. PubMed ID: 19384076
[TBL] [Abstract][Full Text] [Related]
14. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
Vrotsos E; Alexis J
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):26-9. PubMed ID: 25611246
[TBL] [Abstract][Full Text] [Related]
15. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of benign activation of junctional melanocytes and melanoma in situ of the nail unit.
Chu A; André J; Rich P; Leachman S; Thompson CT
J Cutan Pathol; 2019 Jul; 46(7):479-483. PubMed ID: 30887559
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinomas are populated by melanocytes and Langerhans [correction of Langerhan's] cells.
Florell SR; Zone JJ; Gerwels JW
Am J Dermatopathol; 2001 Feb; 23(1):24-8. PubMed ID: 11176048
[TBL] [Abstract][Full Text] [Related]
18. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological, immunohistochemical and fluorescence in-situ hybridisation features of early subungual melanoma: an analysis of 65 cases.
Ren M; Ren J; Cai X; Shen XX; Kong JC; Dai B; Kong YY
Histopathology; 2021 Apr; 78(5):717-726. PubMed ID: 33065755
[TBL] [Abstract][Full Text] [Related]
20. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor.
Glass LF; Raziano RM; Clark GS; Higgins HW; Ladd S; Lien MH; Chen R; Cherpelis BS
Am J Dermatopathol; 2010 Jun; 32(4):319-25. PubMed ID: 20514666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
